Track Hemab Therapeutics Holdings, Inc. Common Stock (COAG) shelf registrations, ATM offerings, warrant and convertible activity, and Nasdaq listing compliance, sourced from SEC filings. The cash position and Nasdaq compliance below are free; the full COAG offering history and dilution risk rating are part of AskEdgar Pro.
Pending and completed COAG offerings, shelf registrations with remaining raisable capacity, at-the-market programs and equity lines, extracted from SEC filings.
Outstanding COAG warrants and convertible notes with exercise and conversion prices, remaining amounts and price-protection terms.
COAG reverse split status, past split ratios, former ticker symbols and lock-up expirations.
Rights attached to past COAG financings and who holds the stock: right of first refusal, participation and registration rights, share issuance restrictions, ownership and legal counsel.
An AI summary of management's commentary on COAG liquidity, going-concern risk and funding plans, plus analyst insights.